α3-adrenoceptor mechanisms in guinea-pig taenia caecum

Life Sciences

Volumn 62, Issue 17-18, 1998, Pages 1503-1507

  Koike, K ^a   Takayanagi, I ^a  

^a TOHO UNIVERSITY   (Japan)

Author keywords

3 adrenoceptors; BRL37344; CGP12177; Norepinephrine; Taenia caecum

Indexed keywords

4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE; 4 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL]PHENOXYACETIC ACID; BETA 3 ADRENERGIC RECEPTOR; CYCLIC AMP; NORADRENALIN; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; ETHANOLAMINE DERIVATIVE; PROPANOLAMINE DERIVATIVE; VASOCONSTRICTOR AGENT;

ANIMAL TISSUE; CECUM TENIA; CONCENTRATION RESPONSE; CONFERENCE PAPER; DRUG RECEPTOR BINDING; NONHUMAN; RECEPTOR DENSITY; REGRESSION ANALYSIS; SMOOTH MUSCLE RELAXATION; ANIMAL; CECUM; DRUG EFFECT; GUINEA PIG; MUSCLE RELAXATION; PHYSIOLOGY; REVIEW; SMOOTH MUSCLE; ULTRASTRUCTURE;

ADRENERGIC BETA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; CECUM; ETHANOLAMINES; GUINEA PIGS; MUSCLE RELAXATION; MUSCLE, SMOOTH; NOREPINEPHRINE; PROPANOLAMINES; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, ADRENERGIC, BETA-3; VASOCONSTRICTOR AGENTS;

EID: 0032571014     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(98)00097-6     Document Type: Conference Paper

References (20)

1. 1. A.M. LANDS, A. ARNOLD, J.P. McANLIFF, F.P. LUDUENA and T.G. BROWN, Nature 214 597-598 (1967).
2. 2. J.R.S. ARCH and A.J. KAUMANN, Med. Res. Rev. 13 663-729 (1993).
3. 3. L.J. EMORINE, S. MARULLO, M.M. BRIEND-SUTREN, G. PATEY, K. TATE, C. DELAVIER-KLUTCHKO and A.D. STROSBERG, Science 245 1118-1121 (1989).
4. 4. K. KOIKE, I. TAKAYANAGI, M. MURAMATSU, S. OHKI and T. HORINOUCHI, Jpn. J. Pharmacol. 66 213-220 (1994).
5. 5. J.R.S. ARCH, AT. AINSWORTH, M.A. CAWTHORNE, V. PIERCY, M.V. SENNITT, V.E. THODY, C. WILSON and S. WILSON, Nature 309 163-165 (1984).
6. 6. C. WILSON, S. WILSON, V. PIERCY, M.V. SENNITT and J.R.S. ARCH, Eur. J. Pharmacol. 100 309-319 (1984).
7. 7. J.R.S. ARCH, Proc. Nutr. Soc. 48 215-223 (1989).
8. 8. R.A. BOND and D.E. CLARKE, Brit. J. Pharmacol. 95 723-734 (1988).
9. 9. D.P. McLAUGHLIN and A. MacDONALD, Brit. J. Pharmacol. 101 569-574 (1990).
10. 10. D.P. McLAUGHLIN and A. MacDONALD, Brit. J. Pharmacol. 103 1351-1356 (1991).
11. 11. J.W. GROWCOTT, B. HOLLOWAY, M. GREEN and C. WILSON, Brit. J. Pharmacol. 110 1375-1380 (1993).
12. 12. R.E.P. DE BOER, F. BROUWER and J. ZAAGSMA, Brit. J. Pharmacol. 110 442-446 (1993).
13. 13. C. HOLLENGA, M. HAAAS, J.T. DEINUM and J. ZAAGSMA, Horm. Metab. Res. 22 17-21 (1990).
14. 14. A. VAN DER VLIET, B. RADEMAKER and A. BAST, J. Pharmacol. Exp. Ther. 255 218-226 (1990).
15. 15. N. BLIN, L. CAMOIN, B. MAIGRET and A.D. STROSBERG, Mol. Pharmacol. 44 1094-1104 (1993).
16. 16. A.J. KAUMANN, Brit. J. Pharmacol. 117 93-98 (1996).
17. 17. A.J. KAUMANN and P. MOLENAAR, Brit. J. Pharmacol. 118 2085-2098 (1996).
18. 18. B. MALINOWSKA and E. SCHLICKER, Brit. J. Pharmacol. 117 943-949 (1996).
19. 19. A.J. KAUMANN, Trends Pharmacol. Sci. 10 316-320 (1989).
20. 20. K.M. TATE, M.M. BRIEND-SUTREN, L.J. EMORINE, C. DELAVIER-KLUTCHKO, S. MARULLO and A.D. STROSBERG, Eur. J. Biochem. 196 357-361 (1991).